Literature DB >> 10669761

The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes.

R B Vega1, J M Huss, D P Kelly.   

Abstract

Peroxisome proliferator-activated receptor alpha (PPARalpha) plays a key role in the transcriptional control of genes encoding mitochondrial fatty acid beta-oxidation (FAO) enzymes. In this study we sought to determine whether the recently identified PPAR gamma coactivator 1 (PGC-1) is capable of coactivating PPARalpha in the transcriptional control of genes encoding FAO enzymes. Mammalian cell cotransfection experiments demonstrated that PGC-1 enhanced PPARalpha-mediated transcriptional activation of reporter plasmids containing PPARalpha target elements. PGC-1 also enhanced the transactivation activity of a PPARalpha-Gal4 DNA binding domain fusion protein. Retroviral vector-mediated expression studies performed in 3T3-L1 cells demonstrated that PPARalpha and PGC-1 cooperatively induced the expression of PPARalpha target genes and increased cellular palmitate oxidation rates. Glutathione S-transferase "pulldown" studies revealed that in contrast to the previously reported ligand-independent interaction with PPARgamma, PGC-1 binds PPARalpha in a ligand-influenced manner. Protein-protein interaction studies and mammalian cell hybrid experiments demonstrated that the PGC-1-PPARalpha interaction involves an LXXLL domain in PGC-1 and the PPARalpha AF2 region, consistent with the observed ligand influence. Last, the PGC-1 transactivation domain was mapped to within the NH(2)-terminal 120 amino acids of the PGC-1 molecule, a region distinct from the PPARalpha interacting domains. These results identify PGC-1 as a coactivator of PPARalpha in the transcriptional control of mitochondrial FAO capacity, define separable PPARalpha interaction and transactivation domains within the PGC-1 molecule, and demonstrate that certain features of the PPARalpha-PGC-1 interaction are distinct from that of PPARgamma-PGC-1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669761      PMCID: PMC85369          DOI: 10.1128/MCB.20.5.1868-1876.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor gamma.

Authors:  Y Zhu; C Qi; C Calandra; M S Rao; J K Reddy
Journal:  Gene Expr       Date:  1996

2.  A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis.

Authors:  P Puigserver; Z Wu; C W Park; R Graves; M Wright; B M Spiegelman
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

3.  Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor.

Authors:  C Mascaró; E Acosta; J A Ortiz; P F Marrero; F G Hegardt; D Haro
Journal:  J Biol Chem       Date:  1998-04-10       Impact factor: 5.157

4.  Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha).

Authors:  T Aoyama; J M Peters; N Iritani; T Nakajima; K Furihata; T Hashimoto; F J Gonzalez
Journal:  J Biol Chem       Date:  1998-03-06       Impact factor: 5.157

5.  A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice.

Authors:  F Djouadi; C J Weinheimer; J E Saffitz; C Pitchford; J Bastin; F J Gonzalez; D P Kelly
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

6.  Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha.

Authors:  J M Brandt; F Djouadi; D P Kelly
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

7.  Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis.

Authors:  P Costet; C Legendre; J Moré; A Edgar; P Galtier; T Pineau
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

8.  Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation.

Authors:  E M McInerney; D W Rose; S E Flynn; S Westin; T M Mullen; A Krones; J Inostroza; J Torchia; R T Nolte; N Assa-Munt; M V Milburn; C K Glass; M G Rosenfeld
Journal:  Genes Dev       Date:  1998-11-01       Impact factor: 11.361

9.  Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.

Authors:  R T Nolte; G B Wisely; S Westin; J E Cobb; M H Lambert; R Kurokawa; M G Rosenfeld; T M Willson; C K Glass; M V Milburn
Journal:  Nature       Date:  1998-09-10       Impact factor: 49.962

10.  Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells.

Authors:  Y T Zhou; M Shimabukuro; M Y Wang; Y Lee; M Higa; J L Milburn; C B Newgard; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

View more
  429 in total

1.  Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor.

Authors:  D Knutti; D Kressler; A Kralli
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

Review 2.  Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility.

Authors:  E H Jeninga; K Schoonjans; J Auwerx
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

Review 3.  Protective effects and mechanisms of sirtuins in the nervous system.

Authors:  Feng Zhang; Suping Wang; Li Gan; Peter S Vosler; Yanqin Gao; Michael J Zigmond; Jun Chen
Journal:  Prog Neurobiol       Date:  2011-09-10       Impact factor: 11.685

4.  Nuclear receptor corepressor RIP140 regulates fat accumulation.

Authors:  Göran Leonardsson; Jenny H Steel; Mark Christian; Victoria Pocock; Stuart Milligan; Jimmy Bell; Po-Wah So; Gema Medina-Gomez; Antonio Vidal-Puig; Roger White; Malcolm G Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-20       Impact factor: 11.205

5.  PGC-1alpha is coupled to HIF-1alpha-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells.

Authors:  Kathleen A O'Hagan; Sinead Cocchiglia; Alexander V Zhdanov; Murtaza M Tambuwala; Murtaza M Tambawala; Eoin P Cummins; Mona Monfared; Terence A Agbor; John F Garvey; Dmitri B Papkovsky; Cormac T Taylor; Bernard B Allan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

6.  BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis.

Authors:  Shu-Wen Qian; Yan Tang; Xi Li; Yuan Liu; You-You Zhang; Hai-Yan Huang; Rui-Dan Xue; Hao-Yong Yu; Liang Guo; Hui-Di Gao; Yan Liu; Xia Sun; Yi-Ming Li; Wei-Ping Jia; Qi-Qun Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-06       Impact factor: 11.205

7.  HIV-1 Vpr induces adipose dysfunction in vivo through reciprocal effects on PPAR/GR co-regulation.

Authors:  Neeti Agarwal; Dinakar Iyer; Sanjeet G Patel; Rajagopal V Sekhar; Terry M Phillips; Ulrich Schubert; Toni Oplt; Eric D Buras; Susan L Samson; Jacob Couturier; Dorothy E Lewis; Maria C Rodriguez-Barradas; Farook Jahoor; Tomoshige Kino; Jeffrey B Kopp; Ashok Balasubramanyam
Journal:  Sci Transl Med       Date:  2013-11-27       Impact factor: 17.956

8.  A Mediator subunit, MDT-15, integrates regulation of fatty acid metabolism by NHR-49-dependent and -independent pathways in C. elegans.

Authors:  Stefan Taubert; Marc R Van Gilst; Malene Hansen; Keith R Yamamoto
Journal:  Genes Dev       Date:  2006-05-01       Impact factor: 11.361

9.  Limited effects of fasting on hepatitis B virus (HBV) biosynthesis in HBV transgenic mice.

Authors:  Lie Li; Claudia E Oropeza; Klaus H Kaestner; Alan McLachlan
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

10.  Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice.

Authors:  M Y Kim; J H Lim; H H Youn; Y A Hong; K S Yang; H S Park; S Chung; S H Ko; S H Koh; S J Shin; B S Choi; H W Kim; Y S Kim; J H Lee; Y S Chang; C W Park
Journal:  Diabetologia       Date:  2012-10-23       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.